Exercise duRing Active Surveillance for prostatE cancer—the ERASE trial: a study protocol of a phase II randomised controlled trial
Introduction Active surveillance (AS) is the preferred primary treatment strategy for men with low-risk clinically localised prostate cancer (PCa); however, the majority of these men still receive radical treatment within 10 years due to disease progression and/or fear of cancer progression. Interve...
Saved in:
| Main Authors: | Dong-Woo Kang, Adrian S Fairey, Normand G Boulé, Catherine J Field, Kerry S Courneya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/7/e026438.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erasing Synapses in Sleep: Is It Time to Be SHY?
by: Marcos Gabriel Frank
Published: (2012-01-01) -
Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study
by: Samuel Smith, et al.
Published: (2025-02-01) -
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial
by: Val Gebski, et al.
Published: (2021-03-01) -
Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – protocol for the ERADICATE study: a phase II randomised controlled trial
by: Oliver Schumacher, et al.
Published: (2025-01-01) -
Exercise prescription improves exercise tolerance in young children with CHD: a randomised clinical trial
by: Brian Grant, et al.
Published: (2021-02-01)